molecular function |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0005138 | | interleukin-6 receptor binding | | Interacting selectively and non-covalently with the interleukin-6 receptor. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
biological process |
| GO:0042110 | | T cell activation | | The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. |
| GO:0072540 | | T-helper 17 cell lineage commitment | | The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17. |
| GO:0006953 | | acute-phase response | | An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals. |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0046849 | | bone remodeling | | The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis. |
| GO:0060445 | | branching involved in salivary gland morphogenesis | | The process in which the branching structure of the salivary gland is generated and organized. |
| GO:0016049 | | cell growth | | The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present. |
| GO:0045454 | | cell redox homeostasis | | Any process that maintains the redox environment of a cell or compartment within a cell. |
| GO:0071549 | | cellular response to dexamethasone stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. |
| GO:0035729 | | cellular response to hepatocyte growth factor stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus. |
| GO:0070301 | | cellular response to hydrogen peroxide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| GO:0071347 | | cellular response to interleukin-1 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
| GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| GO:0071356 | | cellular response to tumor necrosis factor | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
| GO:0019221 | | cytokine-mediated signaling pathway | | A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0050829 | | defense response to Gram-negative bacterium | | Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
| GO:0050830 | | defense response to Gram-positive bacterium | | Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
| GO:0042832 | | defense response to protozoan | | Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism. |
| GO:0051607 | | defense response to virus | | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
| GO:0031018 | | endocrine pancreas development | | The process whose specific outcome is the progression of the endocrine pancreas over time, from its formation to the mature structure. The endocrine pancreas is made up of islet cells that produce insulin, glucagon and somatostatin. |
| GO:0060664 | | epithelial cell proliferation involved in salivary gland morphogenesis | | The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland. |
| GO:0070091 | | glucagon secretion | | The regulated release of glucagon from secretory granules in the A (alpha) cells of the pancreas (islets of Langerhans). |
| GO:0042593 | | glucose homeostasis | | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
| GO:0002384 | | hepatic immune response | | An immune response taking place in the liver. |
| GO:0006959 | | humoral immune response | | An immune response mediated through a body fluid. |
| GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| GO:0070102 | | interleukin-6-mediated signaling pathway | | A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0002548 | | monocyte chemotaxis | | The movement of a monocyte in response to an external stimulus. |
| GO:0046716 | | muscle cell cellular homeostasis | | The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state. |
| GO:0002262 | | myeloid cell homeostasis | | The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| GO:0045079 | | negative regulation of chemokine biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines. |
| GO:0032966 | | negative regulation of collagen biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
| GO:0043154 | | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
| GO:0050710 | | negative regulation of cytokine secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell. |
| GO:0045599 | | negative regulation of fat cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| GO:0045721 | | negative regulation of gluconeogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of gluconeogenesis. |
| GO:0046888 | | negative regulation of hormone secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
| GO:0010888 | | negative regulation of lipid storage | | Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
| GO:0048635 | | negative regulation of muscle organ development | | Any process that stops, prevents, or reduces the frequency, rate or extent of muscle development. |
| GO:1901215 | | negative regulation of neuron death | | Any process that stops, prevents or reduces the frequency, rate or extent of neuron death. |
| GO:0006469 | | negative regulation of protein kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity. |
| GO:0031175 | | neuron projection development | | The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| GO:0001781 | | neutrophil apoptotic process | | Any apoptotic process in a neutrophil, any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. |
| GO:0002446 | | neutrophil mediated immunity | | Any process involved in the carrying out of an immune response by a neutrophil. |
| GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| GO:0050871 | | positive regulation of B cell activation | | Any process that activates or increases the frequency, rate or extent of B cell activation. |
| GO:0045740 | | positive regulation of DNA replication | | Any process that activates or increases the frequency, rate or extent of DNA replication. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0046427 | | positive regulation of JAK-STAT cascade | | Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity. |
| GO:0043410 | | positive regulation of MAPK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
| GO:0051092 | | positive regulation of NF-kappaB transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
| GO:2000366 | | positive regulation of STAT protein import into nucleus | | Any process that activates or increases the frequency, rate or extent of STAT protein import into nucleus. |
| GO:0042102 | | positive regulation of T cell proliferation | | Any process that activates or increases the rate or extent of T cell proliferation. |
| GO:0045630 | | positive regulation of T-helper 2 cell differentiation | | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation. |
| GO:0002675 | | positive regulation of acute inflammatory response | | Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0071864 | | positive regulation of cell proliferation in bone marrow | | A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow. |
| GO:0032722 | | positive regulation of chemokine production | | Any process that activates or increases the frequency, rate, or extent of chemokine production. |
| GO:0050679 | | positive regulation of epithelial cell proliferation | | Any process that activates or increases the rate or extent of epithelial cell proliferation. |
| GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0051024 | | positive regulation of immunoglobulin secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell. |
| GO:0032755 | | positive regulation of interleukin-6 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| GO:0002690 | | positive regulation of leukocyte chemotaxis | | Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis. |
| GO:0045666 | | positive regulation of neuron differentiation | | Any process that activates or increases the frequency, rate or extent of neuron differentiation. |
| GO:0045429 | | positive regulation of nitric oxide biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
| GO:0045669 | | positive regulation of osteoblast differentiation | | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
| GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| GO:0033160 | | positive regulation of protein import into nucleus, translocation | | Any process that activates or increases the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane. |
| GO:0051897 | | positive regulation of protein kinase B signaling | | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| GO:0051091 | | positive regulation of sequence-specific DNA binding transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| GO:0048661 | | positive regulation of smooth muscle cell proliferation | | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| GO:0045727 | | positive regulation of translation | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| GO:0051971 | | positive regulation of transmission of nerve impulse | | Any process that activates, maintains or increases the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. |
| GO:2000676 | | positive regulation of type B pancreatic cell apoptotic process | | Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process. |
| GO:0045765 | | regulation of angiogenesis | | Any process that modulates the frequency, rate or extent of angiogenesis. |
| GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| GO:0008360 | | regulation of cell shape | | Any process that modulates the surface configuration of a cell. |
| GO:0045188 | | regulation of circadian sleep/wake cycle, non-REM sleep | | Any process that modulates the frequency, rate or extent of non-rapid eye movement sleep. |
| GO:0010574 | | regulation of vascular endothelial growth factor production | | Any process that modulates the frequency, rate, or extent of production of vascular endothelial growth factor. |
| GO:0043200 | | response to amino acid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
| GO:0046677 | | response to antibiotic | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
| GO:0010996 | | response to auditory stimulus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an auditory stimulus. |
| GO:0009617 | | response to bacterium | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. |
| GO:0031000 | | response to caffeine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them. |
| GO:0051592 | | response to calcium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| GO:0009409 | | response to cold | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism. |
| GO:0034097 | | response to cytokine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
| GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| GO:0051602 | | response to electrical stimulus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus. |
| GO:0051384 | | response to glucocorticoid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
| GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0032868 | | response to insulin | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| GO:0032496 | | response to lipopolysaccharide | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| GO:0009612 | | response to mechanical stimulus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| GO:0031667 | | response to nutrient levels | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0032494 | | response to peptidoglycan | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule. |
| GO:0009611 | | response to wounding | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
| GO:0001878 | | response to yeast | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a yeast species. |
| GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0005896 | | interleukin-6 receptor complex | | A hexameric protein complex consisting of two molecules each of interleukin-6, interleukin-6 receptor alpha chain, and gp-130. |